Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma

Published:2024-02 Issue:2 Volume:5 Page:101415
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Wang Shun,Zhu Le,Li Tianen,Lin Xinxin,Zheng Yan,Xu Da,Guo Yu,Zhang Ze,Fu Yan,Wang Hao,Wang Xufeng,Zou Tiantian,Shen Xiaotian,Zhang Lumin,Lai Nannan,Lu Lu,Qin Lunxiu,Dong Qiongzhu^ORCID

Funder

Fudan University

Publisher

Elsevier BV

Reference37 articles.

1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021

2. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial;El-Khoueiry;Lancet,2017

3. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial;Zhu;Lancet Oncol.,2018

4. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma;Finn;N. Engl. J. Med.,2020

5. Immunotherapies for hepatocellular carcinoma;Llovet;Nat. Rev. Clin. Oncol.,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy;Frontiers in Immunology;2024-09-09

2. Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation;Redox Biology;2024-09

3. Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects;Apoptosis;2024-07-15

4. IGF2BP1 Bolsters the Chondrocytes Ferroptosis of Osteoarthritis by Targeting m6A/MMP3 Axis;International Journal of General Medicine;2024-05